英文名称 |
中文名称 |
CAS号 |
操作 |
Cucurbitacin I |
葫芦素 I |
2222-07-3 |
详细
|
Ritlecitinib |
利特昔替尼 |
1792180-81-4 |
详细
|
Trimethobenzamide hydrochloride |
盐酸三甲氧苯酰胺 |
554-92-7 |
详细
|
AEBSF hydrochloride |
4-(2-氨乙基)苯磺酰氟盐酸盐 |
30827-99-7 |
详细
|
N-Glycolylneuraminic acid |
N-羟乙酰神经氨酸 |
1113-83-3 |
详细
|
CBS1117 |
化合物CBS1117 |
959245-08-0 |
详细
|
MBX2329 |
1-(2-(2-乙基苯氧基)乙基)氮杂环庚烷盐酸盐 |
1438272-42-4 |
详细
|
Molnupiravir |
莫那比拉韦 |
2492423-29-5 |
详细
|
6-Azathymine |
6-氮杂胸腺嘧啶 |
932-53-6 |
详细
|
Neuraminidase-IN-1 |
Compound Y-1 |
2379438-80-7 |
详细
|
Zapnometinib |
2-(2-CHLORO-4-IODOPHENYLAMINO)-3,4-DIFLUOROBENZOIC ACID |
303175-44-2 |
详细
|
(-)-JNJ-A07 |
化合物 (-)-JNJ-A07 |
2135640-92-3 |
详细
|
Laninamivir |
拉尼米韦 |
203120-17-6 |
详细
|
GSK 650394 |
2-环戊基-4-(5-苯基-1H-吡咯并[2,3-B]吡啶-3-基)苯甲酸 |
890842-28-1 |
详细
|
Ketotifen-d3 (fumarate) |
YNQQEYBLVYAWNX-PCUGBSCUSA-N |
1795138-23-6 |
详细
|
BMS345541 hydrochloride |
N-(1,8-二甲基咪唑并[1,2-A]喹喔啉-4-基)-1,2-乙二胺盐酸盐 |
547757-23-3 |
详细
|
ML 120B dihydrochloride(free base) |
N-(6-氯-7-甲氧基-9H-吡啶并[3,4-B]吲哚-8-基)-2-甲基-3-吡啶甲酰胺 |
783348-36-7 |
详细
|
MRT67307 |
N-[3-[[5-环丙基-2-[[3-(4-吗啉基甲基)苯基]氨基]-4-嘧啶基]氨基]丙基]环丁烷甲酰胺 |
1190378-57-4 |
详细
|
IMD 0354 |
N-[3,5-双(三氟甲基)苯基]-5-氯-2-羟基苯甲酰胺 |
978-62-1 |
详细
|
PS-1145 |
PS-1145 |
431898-65-6 |
详细
|
PF-06263276 |
PF-06263276 (PF 6263276) |
1421502-62-6 |
详细
|
Gusacitinib |
GUSACITINIB |
1425381-60-7 |
详细
|
Fedratinib hydrochloride hydrate |
TG-101348 |
1374744-69-0 |
详细
|
Golidocitinib |
AZD4205 |
2091134-68-6 |
详细
|
Abrocitinib |
PF-04965842(阿布罗替尼) |
1622902-68-4 |
详细
|
Delgocitinib |
迪高替尼 |
1263774-59-9 |
详细
|
Itacnosertib |
N4-([2,2-bipyridin]-3-yl)-N2-(3-methoxy-4-(4-methylpiperazin-1-yl)phenyl)pyrimidine-2,4-diamine |
1628870-27-8 |
详细
|
WHI-P154 |
2-溴-4-(6,7-二甲氧基喹唑啉-4-基氨基)苯酚 |
211555-04-3 |
详细
|
ZM 39923 HCl |
3-[异丙基(苄基)氨基]-1-(2-萘基)-1-丙酮盐酸盐 |
1021868-92-7 |
详细
|
BMS-911543 |
BMS-911543 |
1271022-90-2 |
详细
|
ZM 449829 |
2-萘乙烯基酮 |
4452-06-6 |
详细
|
Decernotinib(VX-509) |
迪西替尼 |
944842-54-0 |
详细
|
WHI-P258 |
WHI-P258 |
21561-09-1 |
详细
|
J30-8 |
J30-8 |
2366255-71-0 |
详细
|
SR-3306 |
化合物SR-3306 |
1128096-91-2 |
详细
|
Tanzisertib |
TANZISERTIB |
899805-25-5 |
详细
|
D-JNKI-1 |
1445179-97-4 |
1445179-97-4 |
详细
|
MPT0B392 |
MPT0B392 |
1346169-92-3 |
详细
|
IQ-1S free acid |
11H-茚并[1,2-b]喹喔啉-11-酮肟 |
23146-22-7 |
详细
|
CC-90001 |
CC90001 |
1403859-14-2 |
详细
|
AS 602801 |
本塔马莫 |
848344-36-5 |
详细
|
Lorpucitinib |
化合物 LORPUCITINIB |
2230282-02-5 |
详细
|
Brepocitinib P-Tosylate |
CS-2860 |
2140301-96-6 |
详细
|
SC99 |
SC-99 |
882290-02-0 |
详细
|
Tyk2-IN-7 |
TYK2-IN-7 (COMPOUND 48) |
1609391-90-3 |
详细
|
BD750 |
2-(2-Benzothiazolyl)-4,5,6,7-tetrahydro-2H-indazol-3-ol |
892686-59-8 |
详细
|
JAK-IN-1 |
JAK-IN-1 |
1334673-53-8 |
详细
|
NVP-BSK805 |
NVP-BSK805 dihydrochloride |
1092499-93-8 |
详细
|
NVP-BSK805 dihydrochloride |
1942919-79-0 |
1942919-79-0 |
详细
|
CEP-33779 |
N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲磺酰基)苯基]-[1,2,4]三唑并[1,5-A]吡啶-2-胺 |
1257704-57-6 |
详细
|
Cerdulatinib hydrochloride |
CERDULATINIB 盐酸盐 |
1369761-01-2 |
详细
|
Itacitinib |
伊他替尼 |
1334298-90-6 |
详细
|
Itacitinib adipate |
1334302-63-4 |
1334302-63-4 |
详细
|
JAK3-IN-1 |
1805787-93-2 |
1805787-93-2 |
详细
|
Ilginatinib |
1239358-86-1 |
1239358-86-1 |
详细
|
Ruxolitinib phosphate |
鲁索利替尼磷酸盐 |
1092939-17-7 |
详细
|
Fedratinib |
N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-[2-(1-吡咯烷基)乙氧基]苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 |
936091-26-8 |
详细
|
G5-7 |
化合物JAK2 INHIBITOR G5-7 |
939681-36-4 |
详细
|
BMS-986202 |
BMS-986202 |
1771691-34-9 |
详细
|
Oclacitinib maleate |
PF-03394197 |
1640292-55-2 |
详细
|
GDC-4379 |
化合物 GDC-4379 |
2252277-73-7 |
详细
|
Pumecitinib |
|
2401057-12-1 |
详细
|
Baricitinib |
巴瑞克替尼 |
1187594-09-7 |
详细
|
Solcitinib |
SOLCITINIB |
1206163-45-2 |
详细
|
Upadacitinib |
乌帕替尼 |
1310726-60-3 |
详细
|
Deucravacitinib |
BMS-986165 |
1609392-27-9 |
详细
|
VVD-118313 |
|
2875046-27-6 |
详细
|
JANEX-1 |
4-(4'-羟基苯基)氨基-6,7-二甲氧基喹唑啉 |
202475-60-3 |
详细
|
Pyridone 6 |
2-(1,1-二甲基乙基)-9-氟-1,6-二氢-7H-苯并[H]咪唑并[4,5-F]异喹啉-7-酮 |
457081-03-7 |
详细
|
SB1317 |
14-甲基-20-氧杂-5,7,14,27-四氮杂四环[19.3.1.1(2,6).1(8,12)]二十七碳-1(25),2,4,6(27),8,10,12(26),16,21,23-十烯 |
937270-47-8 |
详细
|
LY2784544 |
LY 2784544 |
1229236-86-5 |
详细
|
Ivarmacitinib |
化合物SHR0302 |
1445987-21-2 |
详细
|
DB07268 |
2-[[2-[(3-羟基苯基)氨基]-4-嘧啶基]氨基]苯甲酰胺 |
929007-72-7 |
详细
|
Jnk-IN-7 |
3-[[4-(二甲基氨基)-1-氧代-2-丁烯-1-基]氨基]-N-[4-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯基]苯甲酰胺 |
1408064-71-0 |
详细
|
CC-401 |
3-[3-[2-(1-哌啶基)乙氧基]苯基]-5-(1H-1,2,4-三唑-5-基)-1H-吲唑 |
395104-30-0 |
详细
|
Anisomycin |
茴香霉素 |
22862-76-6 |
详细
|
AEG 3482 |
6-苯基咪唑并[2,1-B]-1,3,4-噻二唑-2-磺酰胺 |
63735-71-7 |
详细
|
Kainic acid |
红藻氨酸, ** |
487-79-6 |
详细
|
Nrf2-IN-1 |
1-(4-(tert-butyl)benzyl)-3-(4-chlorophenyl)-N-hydroxy-1H-pyrazole-5-carboxamide |
1610022-76-8 |
详细
|
ML334 |
ML334 |
1432500-66-7 |
详细
|
CDDO-EA |
CS-1305 |
932730-51-3 |
详细
|
CBR-470-2 |
|
2416095-00-4 |
详细
|
DDO-7263 |
化合物DDO-7263 |
2254004-96-9 |
详细
|
(+)-DHMEQ |
287194-41-6 |
287194-41-6 |
详细
|
Ezetimibe-d4-1 |
依折麦布杂质-d4 |
1093659-89-2 |
详细
|
NK-252 |
1414963-82-8 |
1414963-82-8 |
详细
|
Pyridoxine-d3 (hydrochloride) |
Pyridoxine-[D3] HCl (Vitamin B6-[D3]) |
1189921-12-7 |
详细
|
KI696 |
KI-696 |
1799974-70-1 |
详细
|
KI696 isomer |
KI696 isomer |
1799974-69-8 |
详细
|
CDDO-dhTFEA |
RTA dh404 |
1191265-33-4 |
详细
|
4-Octyl Itaconate |
衣康酸盐 |
3133-16-2 |
详细
|
Dimethyl fumarate-d6 |
富马酸二甲酯D6 |
66487-95-4 |
详细
|
Bardoxolone |
2-氰基-3,12-二氧代齐墩果-1,9-二烯-28-酸 |
218600-44-3 |
详细
|
TAK-448 acetate |
TAK-448 acetate |
1470374-22-1 |
详细
|
SR15006 |
SR 15006 |
2505001-54-5 |
详细
|
(R,E)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2- methylpent-2-enoic acid |
LCZ696杂质26对照品 |
1012341-48-8 |
详细
|
(3S,5R)-4-[5-([1,1'-Biphenyl]-4-ylmethyl)-3-methyl-2-oxopyrrolidin-1-yl]-4-oxobutanoic acid |
LCZ696杂质506-07对照品 |
2216746-87-9 |
详细
|
(2R,4S)-4-([1,1'-Biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid |
LCZ696杂质518-12对照品 |
1639970-62-9 |
详细
|
(2R,4S)-4-([1,1'-Biphenyl]-4-ylmethyl)-4-(4-ethoxy-4- oxobutanamido)-2-methylbutanoic acid |
LCZ696杂质522-12对照品 |
149709-49-9 |
详细
|
Propan-2-yl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-2-methyl-4- [4-(propan-2-yloxy)-4-oxobutanamido]butanoate |
LCZ696杂质523-12对照品 |
2216755-67-6 |
详细
|